Viewing Study NCT01295112


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2026-03-26 @ 10:07 AM
Study NCT ID: NCT01295112
Status: COMPLETED
Last Update Posted: 2025-09-25
First Post: 2011-02-10
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein Occlusion
Sponsor: Texas Retina Associates
Organization: